<DOC>
	<DOCNO>NCT01991600</DOCNO>
	<brief_summary>Iron deficiency common micronutrient deficiency world today , affect 60 % global population ( www.who.int/nut/ida.htm ) . The two main strategy prevention treatment iron deficiency involve fortification food iron , direct supplementation iron tablet . Simple iron salt ( e.g . ferrous sulphate ) well absorb supplemental level ( potentially low level , use food fortificants ) induce free radical activity result gastrointestinal side effect systematic oxidative stress . As result , supplementation poor compliance improvement iron status compromise . Ferric salt less inclined produce side effect although relatively well absorbed fortification level food , poorly absorb high supplemental dos . Because certain component food , organic acid , facilitate ferric iron absorption , wish determine whether dietary organic acid may similarly enable efficient absorption supplemental ferric iron prevent formation non-transferrin-bound iron ( NTBI ) proxy free radical activity . Our strategy use iterative process vitro vivo experimentation , aim identify best choice organic acid optimal ratio iron : organic acid . The study cross-over , single-dose comparison standard-of-care therapy ( namely ferrous sulphate ) mildly iron deficient anaemic woman . Both investigational product active comparator administer single dose 2 different occasion , i.e . investigational product first study visit active comparator 14 day later second study visit .</brief_summary>
	<brief_title>A Pilot Study Assess Influence Dietary Organic Acids Iron Absorption .</brief_title>
	<detailed_description>The study first-in-human iron absorption study ferric iron oxide-organic acid preparation ( Fe-OAs ) . The study design cross-over , single-dose , single-blinded comparison standard-of-care therapy ( namely ferrous sulphate ) mildly iron deficient anaemic woman . Methyl-cellulose capsule contain single dos Fe-OAs ( 60 mg elemental iron equivalent ) give four subject per test mixture determine iron absorption bioavailability . The study initially design 2 part ( A B ) . Part A iterative process determine best choice organic acid optimal ratio iron organic acid allow efficient iron absorption , part B comparison absorption two promise Fe-OA preparation standard-of-care therapy ( namely ferrous sulphate ) . Following iterative-based study candidate Fe-OA preparation show nearly equivalent bioavailability ferrous sulphate decide stop study end Part A . On day 1 study ( Part A ) , participant give one methyl-cellulose capsule contain one Fe-OA preparation take empty stomach light breakfast consist water 2 slice white bread jam . Participants blind test preparation receive . Serial serum iron level obtain baseline 30 , 60 , 90 , 120 , 180 , 210 240 minute ingestion iron dosage . Fourteen day later participant return second study visit ingest one ferrous sulphate tablet light breakfast , visit protocol follow . Each subject act control . The bioavailability iron Fe-OA preparation determine measure erythrocyte incorporation label iron 14 day follow single oral dose . Each Fe-OA preparation label 2 mg stable isotope 58Fe per single dose Fe-OA material . Ferrous sulphate use reference oral iron therapy determine individual non-iron absorber . Non-iron absorber define significant net area curve ( AUC ) serum iron follow ferrous sulphate oral ingestion ( i.e . define serum iron increase ≤ 5 μM ) . The data obtain individual exclude final analysis . The bioavailability ferrous sulphate determine use short-term change serum iron level use publish algorithm .</detailed_description>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>Female age 1845 year . Low iron store base one follow criterion : ( I ) Mild iron deficiency anaemia define haemoglobin 1011.9 g/dL plus either serum ferritin le 20 μg/L transferrin saturation &lt; 10 % ( II ) iron deficiency define serum ferritin le 12 μg/L . pregnancy lactation surgery past three month cancer last ten year know chronic infection chronic inflammation moderate severe anaemia know cardiovascular disease chronic respiratory disease . history hereditary haemochromatosis haemoglobinopathy current proton pump inhibitor medication blood donation/heavy blood loss last 3 month iron supplementation past 1 month chronic liver disease renal disease Coeliac Disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>iron absorption</keyword>
	<keyword>bioavailability</keyword>
	<keyword>anaemia</keyword>
	<keyword>iron deficiency</keyword>
	<keyword>ferrous sulphate</keyword>
</DOC>